To view or add a comment, sign in Ahead of print MALAT1 modulates granulosa cells ferroptosis and apoptosis through PAK2 upregulation in polycystic ovary syndrome Highlights MALAT1 controls ferroptosis in KGN granulosa cells, uncovering a novel lncRNA-driven cell-death pathway in ovarian physiology
Nutritional models that increase infertility risk Recently, the key nutrition model pertaining to developed and developing countries has been called the Western diet
By measuring the variation in access to and timeliness of care nationally, the measure builds an evidence base to determine which REHs are meeting benchmarks for emergency care, and which REHs could see improvement
Very informative
Cagrilintide Dose Escalation Studies Phase 2 trials evaluated multiple cagrilintide doses to identify the optimal balance between efficacy and tolerability: 0.3 mg weekly Minimal efficacy, excellent tolerability 0.6 mg weekly Moderate effects, good tolerability 1.2 mg weekly Strong efficacy, acceptable side effects 2.4 mg weekly Optimal efficacy-tolerability balance 4.5 mg weekly Excessive GI side effects outweighed benefits The 2.4 mg weekly dose emerged as the standard in phase 3 trials, providing substantial metabolic benefits while maintaining an acceptable side effect profile[6]
Recent studies have shown its role in inhibiting one of the key components responsible for hyperpigmentation
